ALKERMES | ALKS - Trade Creditors

Stock Price
32.26
Daily Change
0.35 1.10%
Monthly
-2.57%
Yearly
-9.18%
Q1 Forecast
30.94

ALKERMES reported $68M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
ALKERMES USD 68M 31.21M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 24.89M 12.73M Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Malin Corporation EUR 700K 200K Dec/2024
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 945K 48K Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Otsuka Holdings JPY 225.56B 31.54B Dec/2025
Ovoca Bio EUR 209K 242K Dec/2024
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025